INS and type 2 diabetes mellitus: Aggressive insulin treatment of hyperglycemia in non-surgical intensive care unit patients is associated with increased mortality, and intensive glycemic control with mostly exogenous insulin, insulin secretagogues, and metformin does not improve and may even worsen cardiovascular risk in individuals with type 2 diabetes [15, 16].